Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 641-082-3 | (1S, 3S, 5S)-2-((2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyle)-2-azabicyclo[3.1.0]hexane-3-carbonitrile, monohydrate | 945667-22-1 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Skin Sens. 1A | H317 | H317 |
GHS08 Dgr |
State/Form
|
8 | View details | |||||
| Resp. Sens. 1A | H334 | H334 | |||||||||
| Repr. 2 | H361 (Suspected of da...) | H361 | |||||||||
| STOT RE 1 | H372 (endocrine syste...) | H372 | |||||||||
| H361 (d) |
GHS08 Wng |
State/Form
|
1 | View details | |||||||
| Skin Sens. 1 | H317 | H317 |
GHS07 Wng |
State/Form
|
1 | View details | |||||
| Skin Sens. 1A | H317 | H317 |
GHS08 Dgr |
1 | View details | ||||||
| Resp. Sens. 1A | H334 | H334 | |||||||||
| Repr. 2 | H361 (Suspected of da...) | H361 | |||||||||
| STOT RE 1 | H372 (other:endocrine...) | H372 | |||||||||
Number of Aggregated Notifications: 4